Membranoproliferative glomerulonephritis (MPGN) is a glomerular pattern of injury due to different disorders and pathogenic pathways, thus amenable to diverse treatments. A systematic approach allows, in most cases, identification of the underlying cause and a specific treatment.
No takes yet. Share an insight, caveat, or question.
Curiel et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: